Los Angeles Capital Management LLC Procept Bio Robotics Corp Transaction History

Los Angeles Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$48.82 - $65.05 $774,431 - $1.03 Million	-15,863 Reduced 53.42%	13,832 $796,000
Q1 2025 May 05, 2025	BUY	$56.03 - $88.57 $936,541 - $1.48 Million	16,715 Added 128.78%	29,695 $1.73 Million
Q4 2024 Feb 04, 2025	BUY	$67.27 - $99.45 $565,000 - $835,280	8,399 Added 183.34%	12,980 $1.05 Million
Q3 2024 Nov 04, 2024	BUY	$56.31 - $84.99 $257,956 - $389,339	4,581 New	4,581 $366,000

272

49.1M

274K

376K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.32B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.